1. Facial Angiofibroma Severity Index (FASI): reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis‐associated facial angiofibroma. (1st December 2014) Authors: Salido‐Vallejo, R.; Ruano, J.; Garnacho‐Saucedo, G.; Godoy‐Gijón, E.; Llorca, D.; Gómez‐Fernández, C.; Moreno‐Giménez, J. C. Journal: Clinical and experimental dermatology Issue: Volume 39:Number 8(2014) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Facial Angiofibroma Severity Index (FASI): reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis‐associated facial angiofibroma. (20th August 2014) Authors: Salido‐Vallejo, R.; Ruano, J.; Garnacho‐Saucedo, G.; Godoy‐Gijón, E.; Llorca, D.; Gómez‐Fernández, C.; Moreno‐Giménez, J. C. Journal: Clinical and experimental dermatology Issue: Volume 39:Number 8(2014) Page Start: 888 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Positive margins in excised dermatofibrosarcoma protuberans: a study of 58 cases treated with slow‐Mohs surgery. (12th August 2013) Authors: Serra‐Guillén, C.; Llombart, B.; Nagore, E.; Requena, C.; Traves, V.; Llorca, D.; Kindem, S.; Alcalá, R.; Guillén, C.; Sanmartín, O. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 28:Number 8(2014:Aug.) Page Start: 1012 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗